Abstract:Two series of novel N 6 derivatives of 8-azapurine I and II were designed as antiplatelet agents. Series I and II were N 6 amino derivatives and N 6 hydrazone derivatives of 8-azapurine, respectively. The compounds were synthesized in acceptable yields via conventional procedures, including nucleophilic substitution, diazotization, and amination or hydrazonation with amino alcohol and 4,6-dichloropyrimidine as starting materials. To assess the ability of the synthesized compounds as antiplatelet agents, the ADP-induced platelet aggregation assay of Born was performed both in vitro and in vivo using ticagrelor as a reference control substance. The analysis of the structure-activity relationship and molecular docking were also discussed in detail. The results demonstrated that series I and II compounds exhibited antiplatelet activity in vitro and IIh was the most active compound (IC50 = 0.20 μM) among the target compounds, being almost 4-fold better than ticagrelor (IC50 = 0.74 μM). For a preliminary assessment of the safety profile, a bleeding test (mouse tail) and a single-dose toxicity test were conducted. The use of compound IIh resulted in a shorter bleeding time, less blood loss and lower acute toxicity compared to ticagrelor. In addition, a molecular docking study was performed to investigate the binding capacity and binding mode between IIh and P2Y12.

Novel Synthesis Approach and Antiplatelet Activity Evaluation of 6-Alkylamino-2,4-dialkyl(aryl)thiopyrimidines

ChemInform Abstract: Novel Synthesis Approach and Antiplatelet Activity Evaluation of 6‐Alkylamino‐2,4‐dialkyl(aryl)thiopyrimidines.

New Approach to Synthesize Symmetrical and Unsymmetrical 6-(N-alkyl(aryl)amino)- and 6-(N,n-dialkyl(aryl)amino)-2,4-bis(alkyl(aryl)thio)pyrimidines As Anti-Platelet Agents

Synthesis of N-6-Alkyl(Aryl)-2-Alkyl(Aryl)Thioadenosines As Antiplatelet Agents

Synthesis and Anti-platelet Aggregation Activities of Novel N-substituted-tetrahydrothieno [3,2-C] Pyridine Derivatives

Synthesis of Pyridazinone Derivatives and Study of Their Antiplatelet Aggregation Activity

Synthesis and Antithrombotic Activity of 3-Aryl-1,2,3,4-oxatriazole-5-imine-coupled Aspirin

Synthesis and Antiplatelet Aggregative Activity of 6-[4-(substituted Amino Acet-Amido-phenyl)]-4,5-dihydro-3(2 H)-pyridazinones

Synthesis and biological evaluation of N 6 derivatives of 8-azapurine as novel antiplatelet agents

Synthesis and Antiplatelet Aggregation Activity of Dihydropyridazinone Derivatives

Synthesis and Biological Evaluation of N6 Derivatives of 8-Azapurine As Novel Antiplatelet Agents

Synthesis and Antiplatelet Activities of N-Arylmethyl-3,4-dimethylpyrano(2,3-c)pyrazol-6-one Derivatives.

Synthesis and platelet aggregation inhibition activity of new derivatives of pyridazinone

Synthesis and Antitumor Activity Evaluation of Novel 2-Amino-5-ethylpyrimidine Derivatives

Synthesis and antiplatelet aggregation activities of prasugrel derivatives

Synthesis, Molecular Docking, and Hemorheological Activity of New 4-(Thien-2-yl)-3-aminopyridine-2(1H)-one Derivatives

Synthesis and Antitumor Activity of Α-Aminophosphonate Derivatives Containing Thieno[2,3-D]pyrimidines

Synthesis and antiproliferative activities of novel 2-substituted-4-aminothieno[3,2-d]pyrimidine derivatives

Design And Synthesis Of New Arylsulfonamide And Arylamide Derivatives For The Platelet Aggression Inhibitor

Synthesis and Biological Evaluation of Novel Thiadiazole Derivatives as Antiplatelet Agents

Synthesis and Biological Evaluation of N-Butylphthalide Derivatives As Anti-Platelet Aggregation Agents